Sökning: id:"swepub:oai:DiVA.org:uu-15120" >
Population pharmaco...
Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients : a study by the EORTC-PAMM-NDDG
-
Joerger, Markus (författare)
-
Huitema, Alwin D R (författare)
-
Richel, Dick J (författare)
-
visa fler...
-
Dittrich, Christian (författare)
-
Pavlidis, Nikolas (författare)
-
Briasoulis, Evangelos (författare)
-
Vermorken, Jan B (författare)
-
Strocchi, Elena (författare)
-
Martoni, Andrea (författare)
-
Sorio, Roberto (författare)
-
Sleeboom, Henk P (författare)
-
Izquierdo, Miguel A (författare)
-
Jodrell, Duncan I (författare)
-
Féty, Régine (författare)
-
de Bruijn, Ernst (författare)
-
Hempel, Georg (författare)
-
- Karlsson, Mats (författare)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
Tranchand, Brigitte (författare)
-
Schrijvers, Ad H G J (författare)
-
Twelves, Chris (författare)
-
Beijnen, Jos H (författare)
-
Schellens, Jan H M (författare)
-
visa färre...
-
(creator_code:org_t)
- 2007
- 2007
- Engelska.
-
Ingår i: Clinical Pharmacokinetics. - 0312-5963 .- 1179-1926. ; 46:12, s. 1051-1068
- Relaterad länk:
-
https://urn.kb.se/re...
Abstract
Ämnesord
Stäng
- Aims: To investigate the population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients. Patients and methods: Sixty-five female patients with early or advanced breast cancer received doxorubicin 60 mg/m(2) over 15 minutes followed by cyclophosphamide 600 mg/m(2) over 15 minutes. The plasma concentration-time data of both drugs were measured, and the relationship between drug pharmacokinetics and neutrophil counts was evaluated using nonlinear mixed-effect modelling. Relationships were explored between drug exposure (the area under the plasma concentration-time curve [AUC]), toxicity and tumour response. Results: Fifty-nine patients had complete pharmacokinetic and toxicity data. In 50 patients with measurable disease, the objective response rate was 60%, with complete responses in 6% of patients. Both doxorubicin and cyclophosphamide pharmacokinetics were associated with neutrophil toxicity. Cyclophosphamide exposure (the AUC) was significantly higher in patients with at least stable disease (n = 44) than in patients with progressive disease (n = 6; 945 mu mol . h/L [95% CI 889, 1001] vs 602 mu mol . h/L [95% CI 379, 825], p = 0.0002). No such correlation was found for doxorubicin. Body surface area was positively correlated with doxorubicin clearance; AST and patient age were negatively correlated with doxorubicin clearance; creatinine clearance was positively correlated with doxorubicinol clearance; and occasional concurrent use of carbamazepine was positively correlated with cyclophosphamide clearance. Conclusions: The proposed inhibitory population pharmacokinetic-pharmacodynamic model adequately described individual neutrophil counts after administration of doxorubicin and cyclophosphamide. In this patient population, exposure to cyclophosphamide, as assessed by the AUC, might have been a predictor of the treatment response, whereas exposure to doxorubicin was not. A prospective study should validate cyclophosphamide exposure as a predictive marker for the treatment response and clinical outcome in this patient group
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
Nyckelord
- Breast cancer
- Cyclophosphamide
- Doxorubicin
- Pharmacokinetic modelling
- Population pharmacokinetics
- PHARMACY
- FARMACI
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Joerger, Markus
-
Huitema, Alwin D ...
-
Richel, Dick J
-
Dittrich, Christ ...
-
Pavlidis, Nikola ...
-
Briasoulis, Evan ...
-
visa fler...
-
Vermorken, Jan B
-
Strocchi, Elena
-
Martoni, Andrea
-
Sorio, Roberto
-
Sleeboom, Henk P
-
Izquierdo, Migue ...
-
Jodrell, Duncan ...
-
Féty, Régine
-
de Bruijn, Ernst
-
Hempel, Georg
-
Karlsson, Mats
-
Tranchand, Brigi ...
-
Schrijvers, Ad H ...
-
Twelves, Chris
-
Beijnen, Jos H
-
Schellens, Jan H ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Farmaceutiska ve ...
- Artiklar i publikationen
-
Clinical Pharmac ...
- Av lärosätet
-
Uppsala universitet